Ulland Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Ulland Investment Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56K	Hold	615	–	–	0.04%	118
2026 Q1	$49K	Hold	615	–	–	0.04%	116
2025 Q4	$52K	Hold	615	–	–	0.04%	116
2025 Q3	$48K	Hold	615	–	–	0.04%	118
2025 Q2	$48K	Hold	615	–	–	0.04%	110
2025 Q1	$45K	Hold	615	–	–	0.04%	114
2024 Q4	$46K	Hold	615	–	–	0.03%	117
2024 Q3	$41K	Hold	615	–	–	0.03%	112
2024 Q2	$57K	Sell	615 -165	-21%	-$14.6K	0.04%	106
2024 Q1	$75K	Hold	780	–	–	0.06%	98
2023 Q4	$59K	Hold	780	–	–	0.06%	95
2023 Q3	$54K	Hold	780	–	–	0.06%	103
2023 Q2	$74K	Hold	780	–	–	0.08%	89
2023 Q1	$65K	Hold	780	–	–	0.08%	82
2022 Q4	$58K	Hold	780	–	–	0.07%	88
2022 Q3	$64K	Sell	780 -155	-17%	-$14.9K	0.07%	83
2022 Q2	$89K	Hold	935	–	–	0.09%	70
2022 Q1	$110K	Buy	935 +155	+20%	+$17.4K	0.08%	74
2021 Q4	$101K	Buy	+780	New	+$91K	0.06%	80

Other funds holding EW

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ulland Investment Advisors's EW Position: Q2 2026 in Review

Ulland Investment Advisors held its Edwards Lifesciences (EW) position steady in Q2 2026 at 615 shares worth $56K. The position accounts for 0.04% of the portfolio, ranked #118.

Ulland Investment Advisors first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $110K in Q1 2022. 720 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Ulland Investment Advisors held 615 shares of Edwards Lifesciences worth $56K as of Q2 2026.
Ulland Investment Advisors left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.04% of Ulland Investment Advisors's portfolio in Q2 2026, its #118 holding.
Ulland Investment Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
Ulland Investment Advisors's Edwards Lifesciences position peaked at $110K in Q1 2022.
720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.